| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 01/30/2003 | CA2451392A1 Prostaglandin analogues as ep4 receptor agonists |
| 01/30/2003 | CA2451104A1 Electro-medical device for use with biologics |
| 01/30/2003 | CA2450437A1 1-phenylsulphonyl-1,3-dihydro-2h-indol-2-one derivatives, their preparation and their therapeutic application |
| 01/30/2003 | CA2448724A1 2-methyl-thieno-benzodiazepine lyophilized formulation |
| 01/30/2003 | CA2418117A1 Antitumor agent |
| 01/30/2003 | CA2417955A1 Quinazolines, pharmaceutical compositions containing these compounds, their use and processes for preparing them |
| 01/30/2003 | CA2417907A1 Bicyclic heterocycles, pharmaceutical compositions containing these compounds, their use and processes for preparing them |
| 01/30/2003 | CA2417845A1 Preventive or therapeutic drugs for cancers containing cyanidin compounds as the active ingredient |
| 01/30/2003 | CA2417842A1 Method for producing lipoic acid and dihydrolipoic acid |
| 01/30/2003 | CA2417804A1 Method for the production of imidazo-(1,2-c)(2,3)-benzodiazepines and intermediates in the production thereof |
| 01/29/2003 | WO2002009713A2 Selective pde 2 inhibitors, used as medicaments for improving cognition |
| 01/29/2003 | EP1279676A1 Porphyrin derivatives for photodynamic therapy |
| 01/29/2003 | EP1279674A2 Acetylenic ortho-sulfonamido and phosphinic acid amido bicyclic heteroaryl hydroxamic acids as TACE inhibitors |
| 01/29/2003 | EP1279666A1 1-diphenylmethyl-pyrazole derivatives as opioid receptor ligands |
| 01/29/2003 | EP1279662A1 Process for preparing phenylcyclohexan-1-ylcarboxylic acids |
| 01/29/2003 | EP1279412A2 Pressure-mediated intracellular delivery of molecules of microparticles |
| 01/29/2003 | EP1279404A1 Use of HIV-1 tat, fragments or derivatives thereof, to target or to activate antigen-presenting cells, to deliver cargo molecules for vaccination or to treat other diseases |
| 01/29/2003 | EP1279402A1 Coated granules of allylamine-or benzylamine-anti-mycotics, process for preparation thereof and orodispersible tablets containing said coated granules |
| 01/29/2003 | EP1279400A1 Modifying the fatty acid composition of cell membranes of organs and tissues |
| 01/29/2003 | EP1278893A2 Diagnosis of diseases associated with dna replication |
| 01/29/2003 | EP1278881A1 Hybrid glycosylated products and their production and use |
| 01/29/2003 | EP1278851A1 Humanised antibodies to the epidermal growth factor receptor |
| 01/29/2003 | EP1278849A2 Thrombopoietin receptor modulating peptide |
| 01/29/2003 | EP1278842A2 Dna encoding the prost 03 polypeptide |
| 01/29/2003 | EP1278836A1 Compound, composition and method for the treatment of inflammatory and inflammatory-related disorders |
| 01/29/2003 | EP1278833A2 Method for producing genomic libraries and genomic libraries produced therewith |
| 01/29/2003 | EP1278763A1 3-nitrogen-6,7-dioxygen steroids and uses related thereto |
| 01/29/2003 | EP1278761A2 MODULATION OF OLIGONUCLEOTIDE CpG-MEDIATED IMMUNE STIMULATION BY POSITIONAL MODIFICATION OF NUCLEOSIDES |
| 01/29/2003 | EP1278759A1 Bis-(n,n'-bis-(2-haloethyl)amino) phosphoramidates as antitumor agents |
| 01/29/2003 | EP1278755A2 Azole compounds as therapeutic agents for fungal infections |
| 01/29/2003 | EP1278751A1 Tricyclic fused pyridine and pyrimidine derivatives as crf receptor antagonists |
| 01/29/2003 | EP1278750A1 Imidazopyrimidine derivatives and triazolopyrimidine derivatives |
| 01/29/2003 | EP1278749A1 USE OF 5-THIO-, SULFINYL- AND SULFONYLPYRAZOLO 3,4-b]-PYRIDINES AS CYCLIN DEPENDENT KINASE INHIBITORS |
| 01/29/2003 | EP1278748A2 Inhibitors of human phosphatidyl-inositol 3-kinase delta |
| 01/29/2003 | EP1278747A1 Pyrano, piperidino, and thiopyrano compounds and methods of use |
| 01/29/2003 | EP1278746A2 Dihydropyridine compounds and methods of use |
| 01/29/2003 | EP1278744A1 Heterobicyclic sulfonamides and their use as platelet adp receptor inhibitors |
| 01/29/2003 | EP1278743A1 Novel anti-infectives |
| 01/29/2003 | EP1278742A1 Chromenylmethylpyrimidinediamines as antibacterial agents |
| 01/29/2003 | EP1278741A1 Muscarinic agonists |
| 01/29/2003 | EP1278740A1 Hydroxyphenyl-piperazinyl-methyl-benzamide derivatives for the treatment of pain |
| 01/29/2003 | EP1278739A1 Amino substituted dibenzothiophene derivatives for the treatment of disorders mediated by the np y5 receptor |
| 01/29/2003 | EP1278736A1 Quaternary salts of n-substituted cyclic or acyclic amines as pharmaceuticals |
| 01/29/2003 | EP1278735A1 2,4-di(hetero-)arylamino(-oxy)-5-substituted pyrimidines as antineoplastic agents |
| 01/29/2003 | EP1278734A2 Method of treatment using phenyl and biaryl derivatives as prostaglandin e inhibitors and compounds useful therefore |
| 01/29/2003 | EP1278732A1 1-aroyl-piperidinyl benzamidines |
| 01/29/2003 | EP1278731A1 Cyclic quaternary ammonium compounds |
| 01/29/2003 | EP1278730A2 4-benzyl-1- 2-(4-hydroxy-phenoxy)-ethyl]-piperidine-3,4-diol |
| 01/29/2003 | EP1278729A1 Benzosuberonylpiperidine compounds as analgesics |
| 01/29/2003 | EP1278728A1 Pyrrolidine and piperidine derivatives and their use for the treatment of neurodegenerative disorders |
| 01/29/2003 | EP1278723A2 P-(sulfonyl)-aryl and -heteroaryl amines |
| 01/29/2003 | EP1278722A1 Aryl and heteroaryl sulfonates |
| 01/29/2003 | EP1278719A1 Naphthamide neurokinin antagonists for use as medicaments |
| 01/29/2003 | EP1278716A1 Cyclohexylamine derivative as subtype selective nmda receptor antagonists |
| 01/29/2003 | EP1278574A2 Topical composition for the treatment of psoriasis and related skin disorders |
| 01/29/2003 | EP1278547A2 Formulations and methods of using nitric oxide mimetics against a malignant cell phenotype |
| 01/29/2003 | EP1278546A1 Combination therapy of respiratory diseases using antibodies and anti-inflammatory agents |
| 01/29/2003 | EP1278545A1 Combination therapy of respiratory diseases using antibodies |
| 01/29/2003 | EP1278543A2 Antibody binding alpha4beta7 integrin and its use to treat inflammatory bowel disease |
| 01/29/2003 | EP1278540A2 Use of il-18 inhibitors for the treatment and/or prevention of atherosclerosis |
| 01/29/2003 | EP1278537A2 Methods for stimulating nervous system regeneration and repair by regulating arginase i and polyamine synthesis |
| 01/29/2003 | EP1278535A2 Uses of tgap7 for the modulation of leucocyte activation |
| 01/29/2003 | EP1278528A1 Nucleoside analogs with carboxamidine-modified bicyclic base |
| 01/29/2003 | EP1278527A1 Derivatives of polyene macrolides and preparation and use thereof |
| 01/29/2003 | EP1278526A2 Treatment of cerebrovascular disease |
| 01/29/2003 | EP1278525A2 Methods and compositions for enhancing cellular function through protection of tissue components |
| 01/29/2003 | EP1278524A1 Medical combinations comprising mometasone and salmeterol |
| 01/29/2003 | EP1278523A2 Combination of progesterone and mifepristone for cancer therapy |
| 01/29/2003 | EP1278522A2 Pde-v inhibitors for treatment of parkinson's disease |
| 01/29/2003 | EP1278521A2 Use of n-heterocyclic substituted salicylates for inhibition of cellular uptake of cystine |
| 01/29/2003 | EP1278520A1 Diaryl piperidyl pyrrole derivatives as antiprotozoal agents |
| 01/29/2003 | EP1278518A2 A composition comprising camptothecin and a pyrimidine derivative for the treatment of cancer |
| 01/29/2003 | EP1278517A2 Methods for improving size and appearance of a wound |
| 01/29/2003 | EP1278516A1 Powders for use in a dry powder inhaler |
| 01/29/2003 | EP1278515A1 Pharmaceutical formulation comprising carrier beads coated with a layer of valaciclovir |
| 01/29/2003 | EP1278513A2 A core formulation |
| 01/29/2003 | EP1278509A1 Lipochroman-6 as no-synthase inhibitor and uses |
| 01/29/2003 | EP1278502A2 Protease inhibitors |
| 01/29/2003 | EP1278495A1 Topical compositions containing prostaglandin e 1? |
| 01/29/2003 | EP1278494A1 Device and method for treating urinary incontinence in females |
| 01/29/2003 | EP1278493A1 Apparatus and method for delivering compounds to a living organism |
| 01/29/2003 | EP1278417A1 Compositions and methods of treating, reducing, and preventing cardiovascular diseases and disorders with polymethoxyflavones |
| 01/29/2003 | EP1278412A2 Polymer conjugates of ara-c and ara-c derivatives |
| 01/29/2003 | EP1210349B1 PYRAZOLO 4,3-d]PYRIMIDINES |
| 01/29/2003 | EP1182931A4 Stable biocidal compositions |
| 01/29/2003 | EP1178990B1 Imidazodiazepine derivative |
| 01/29/2003 | EP1161434B1 Pyridopyranoazepine derivatives, preparation and therapeutic use |
| 01/29/2003 | EP1129097B1 Novel type condensed pyridazinone compounds |
| 01/29/2003 | EP1119334B1 Two chamber cartridge for atomizers |
| 01/29/2003 | EP1117669B1 Antiviral purine derivatives |
| 01/29/2003 | EP1115725B1 Tetrahydropyridoethers |
| 01/29/2003 | EP1112280B1 Method of preparing form ii crystals of clarithromycin |
| 01/29/2003 | EP1105387B1 Prodrugs of proton pump inhibitors |
| 01/29/2003 | EP1104425B1 Novel thiazolopyrimidine compounds |
| 01/29/2003 | EP1102761B1 Cyclopentabenzofuran derivatives and their use |
| 01/29/2003 | EP1087980B1 Derivatives of 3-(2-oxo- 1,3']bipyrrolidinyl-3-ylidenemethyl)-cephems |
| 01/29/2003 | EP1064259B1 N,N'-Diacylthiocystines |
| 01/29/2003 | EP1064257B1 Anti-tumour agents |
| 01/29/2003 | EP1064253B1 Anti-tumour agents |
| 01/29/2003 | EP1040107B1 6-o-alkyl derivatives of erythronolide b |